Leverette 21

Ethinylestradiol, the active ingredient in Leverette 21, is a combined oral contraceptive presented as a tablet for oral use. It works together with levonorgestrel to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. The formulation provides a steady hormonal dose that aligns with the monthly menstrual cycle, offering reliable contraceptive efficacy when taken as directed.

GNH USA supplies Leverette 21 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Leverette 21, a combined oral contraceptive, is used within the hormonal contraceptive pathway to prevent pregnancy.

Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed.

Leverette 21 may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset often occurring early in treatment. - Headache: transient tension or migraine‑type pain. - Breast tenderness: temporary swelling or discomfort. - Irregular bleeding: spotting or breakthrough bleeding between periods. - Weight gain: modest increase in body weight reported by some users.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism requiring immediate medical attention. - Hypertension: significant rise in blood pressure that may need treatment. - Liver disorders: jaundice or abnormal liver function tests. - Allergic reaction: rash, itching, or swelling that may indicate hypersensitivity. - Stroke: rare cerebrovascular event, especially in women with additional risk factors.

Before prescribing Leverette 21, clinicians should evaluate patient history and counsel on safe use.

- Smoking status: avoid use in women over 35 who smoke due to increased thrombotic risk. - Cardiovascular disease: contraindicated in patients with history of myocardial infarction, stroke, or uncontrolled hypertension. - Migraine with aura: not recommended because of elevated stroke risk. - Liver disease: use with caution in patients with active liver disease. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Leverette 21 can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase risk of thrombosis. - Enzyme inducers (e.g., rifampicin, carbamazepine): reduce hormonal levels, decreasing contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., phenytoin): may lower hormone concentrations. - Antiretrovirals (e.g., efavirenz): can diminish contraceptive effect. - Herbal supplements (e.g., St. John’s wort): may decrease oral contraceptive effectiveness.